Simcyp

This week, Certara, a software and scientific consulting vendor, launched the Cardiac Safety Simulator, a tool that lets pharmaceutical companies test the toxicity of potential drug candidate on the heart using an in silico model of ventricular cells and determine safe dosage reg

GenBank 194.0 is now available via FTP from the National Center for Biotechnology Information.

Simcyp, a division of Certara, said this week that it has entered into a Cooperative Research and Development Agreement with the US Food and Drug Administration to further develop the Simcyp Dog model for the evaluation of drug products intended for use in different canine breeds

Researchers from the Victorian Bioinformatics Consortium have released version 2.2.4 of the Velvet Optimiser, which includes a several bug fixes.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.